Archives
-
Acetylcholine Chloride in Gut–Brain Assays
2026-09-08
Acetylcholine Chloride offers a defined way to interrogate acetylcholine neurotransmitter signaling across gut, vagal, and neuronal preparations. This article translates recent Bacteroides fragilis findings into a causality-focused assay strategy rather than simply repeating the study’s seizure biology.
-
BAPTA: A Causal Tool for Calcium Signaling
2026-09-08
BAPTA is a high-affinity calcium chelator for testing whether intracellular Ca2+ changes drive apoptosis and pathway activation. This article develops a causality-focused assay framework using the IP3R/Ca2+/STAT3 findings in intestinal toxicology while addressing chelator handling, controls, and interpretation.
-
Rosiglitazone for Reliable Cell Assays
2026-09-07
A scenario-driven guide to using Rosiglitazone (SKU A4304) in viability, proliferation, adipogenesis, and metabolic assays. It explains solvent control, stock preparation, data interpretation, and vendor-selection criteria for more defensible PPARγ experiments.
-
Thioredoxin Control of CHK1 Inhibitor Sensitivity
2026-09-07
The 2024 Nature Communications study identifies thioredoxin 1 as a determinant of CHK1 inhibitor response in non-small cell lung cancer. It connects thioredoxin-dependent redox recycling of RRM1 with ribonucleotide reductase activity and deoxynucleotide availability, providing a mechanistic rationale for combining CHK1 and thioredoxin reductase inhibition.
-
Meropenem in Reliable Cell Viability Workflows
2026-09-05
Learn how Meropenem (SKU A5124) can help control bacterial variables in cell viability, proliferation, and infection-model assays. This scenario-based guide connects product specifications with resistance-aware experimental design, solvent control, and interpretation of cytotoxicity data.
-
Protein A/G Magnetic Co-IP/IP Kit for RNF8–DAPK1 Studies
2026-09-04
Translate the RNF8–DAPK1 interaction reported in an ischemic-stroke model into a practical, control-rich Co-IP workflow. Magnetic separation supports rapid protein complex isolation, SDS-PAGE, mass spectrometry, and antibody purification using magnetic beads across compatible biological samples.
-
Targeted SPP1 Inhibition in Tumor-Associated Myeloid Cells
2026-09-04
Kartal et al. developed a macrophage-based phenotypic screen to identify small-molecule modulators that reduce SPP1 expression, then incorporated lead compounds into a TAM-avid polymeric nanoconstruct. The lead formulation suppressed SPP1 in vitro and in vivo and produced tumor remissions in multiple murine models, establishing a practical framework for targeting tumor-promoting myeloid cells.
-
Alosetron in Intestinal Signaling Research
2026-09-03
Use Alosetron as a selective 5-HT3 receptor antagonist to separate serotonin-driven epithelial responses from CDC42–YAP–EGF–mTOR regulation. This assay-focused workflow combines receptor pharmacology, intestinal organoid phenotyping, and polarity readouts without implying that Alosetron was used in the reference study.
-
Y-27632 Dihydrochloride for Organoid Workflows
2026-09-03
Y-27632 dihydrochloride gives organoid and stem-cell researchers a reversible way to control dissociation stress, cytoskeletal remodeling, and early post-seeding survival. This guide connects ROCK inhibition with the Paneth-cell–intestinal stem-cell findings of a recent Nature Communications study while separating validated biology from practical assay recommendations.
-
5-hme-dCTP for DNA Hydroxymethylation Assays
2026-09-02
5-hme-dCTP gives researchers a defined DNA polymerase substrate for building hydroxymethylated controls, testing assay performance, and studying epigenetic DNA modification. Its greatest value is as a workflow-enabling reagent for low-abundance 5hmC measurements, including plant drought response epigenetics, rather than as a stand-alone detector of native DNA marks.
-
RCN2 Links ESCC Metastasis to Cisplatin Resistance
2026-09-02
This study identifies reticulocalbin 2 (RCN2) as a mechanistic driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance. Its central finding is that RCN2 promotes UBR5-dependent PPP2CA ubiquitination and degradation, activating PI3K–AKT signaling and exposing a potential vulnerability for combination treatment.
-
Liproxstatin-1 HCl Ferroptosis Workflows
2026-09-01
Liproxstatin-1 HCl provides a selective way to confirm ferroptotic lipid damage in cellular and organ-injury research. This practical guide connects nanomolar inhibition with assay design, mitochondrial calcium biology, acute renal failure models, hepatic ischemia/reperfusion injury, and troubleshooting strategies.
-
EZ Cap™ Mouse IL-12 mRNA Workflow
2026-09-01
A bench-ready guide to using EZ Cap™ Mouse IL-12 mRNA (m1Ψ) for cytokine expression, T-cell and NK-cell assay development, and delivery-platform testing. It connects practical handling and optimization with evidence from an extrahepatic virus-mimicking particle study, while separating validated findings from assay-development recommendations.
-
Hyaluronic Acid Sodium Salt for siRNA Nanoparticles
2026-08-31
Hyaluronic acid sodium salt helps researchers connect extracellular-matrix modeling with targeted siRNA nanoparticle workflows. Its high-molecular-weight, anionic profile supports coating optimization, immune-cell assays, organoid studies, and troubleshooting of nanoparticle–cell interactions.
-
WAY-100635: A Receptor-Logic Framework
2026-08-31
WAY-100635 enables selective interrogation of 5-HT1A signaling across binding, behavioral, and imaging experiments. This article develops an assay-decision framework linking receptor pharmacology with emerging evidence on pain, affect, and serotonergic circuit activity.